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Abstract
Background: Nuclear protein in testis (NUT) carcinoma (NC) is an aggressive type of
poorly differentiated carcinoma with a variable degree of squamous differentiation.
NC is defined by the presence of BRD-NUT fusion oncogenes, the most common
fusion form being the BRD4-NUTM1 gene. Variant rearrangements involving the
BRD3 and NSD3 genes. Variant rearrangements involving the BRD3 and NSD3
genes occur in approximately one-third of the cases.
Aims: This is the first case regarding the study of cytological features of NC of the
lung with BRD3-NUTM1 fusion.
Materials and Methods: A 36-year-old female with chest heaviness and shortness of
breath was found to have a right-sided pleural effusion; she was non-smoker and denied
any significant past medical illness. CT-chest revealed an 8.5 cm heterogeneous mass in
the right and mid-upper lung. She underwent endobronchial ultrasound-guided (EBUS)
transbronchial fine-needle aspiration (FNA) of the lung mass. Thoracocentesis was performed, and pleural fluid was sent to the laboratory for cytological evaluation
Results: The cytopathological findings showed atypical squamoid cells with variably prominent single or multiple nucleoli. Monotonous-looking cells with high nuclear to cytoplasmic
ratio and hyperchromasia were also present. The atypical squamoid cells showed abundant
clear to eosinophilic cytoplasm with rare individual cell keratinization and focal keratin pearl
formation. The atypical cells were positive for CK7, p40, p63, mCEA and equivocal for
NUT-specific antibody. The cytopathological findings were consistent with squamous cell
carcinoma with focal keratinization. The Fusion Panel-Solid Tumor (50 genes) revealed
BRD3-NUTM1 fusion gene. Diagnosis was amended to pulmonary NC.
Discussion: NC is a diagnostic challenge for pathologists as it can morphologically
mimic undifferentiated carcinoma, squamous cell carcinoma, or neuroendocrine carcinoma. The challenge is not how to diagnose NC but rather determining when to
include it in the differential diagnosis and perform the diagnostic molecular tests
(FISH or NGS) or IHC study for NUT-specific antibody.
Conclusion: When a specimen demonstrates a dual cell population of squamoid cells
and primitive-looking tumor cells in the wrong clinical context (i.e., young patient
with no smoking history), further molecular profiling is warranted to include the differential of a primary NC of the lung. The cytological features of NC itself have rarely
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been documented and moreover, that of a primary NC of the lung with BRD3NUTM1 fusion has never been reported. We herein report cytological findings of a
primary NC of the lung with BRD3-NUTM1 fusion gene.
KEYWORDS

BRD3-NUTM1 fusion gene, carcinoma, cytology, EBUS, NUT carcinoma
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I N T RO DU CT I O N

Nuclear protein in testis (NUT) carcinomas (NC) are aggressive,
poorly differentiated carcinomas with varying degrees of squamous
differentiation. NC is defined by the presence of BRD-NUT fusion
oncogenes. NUT gene on chromosome 15q14 is involved in a balanced translocation with the BRD4 gene on chromosome
19p13.1.1 Variant rearrangements involving the BRD3, and NSD3
gene occur in approximately one-third of the cases. These fusion
genes promote cell growth and inhibit differentiation through aberrant histone acetylation and activation of MYC, contributing to the
aggressive phenotype.2 There is no known association with exposures to environmental toxins or infectious agents, smoking, or
oncogenic viruses such as the Human papillomavirus or Epstein–
Barr virus.3
NC presents most commonly in midline structures of the body,
such as in the head, neck, or mediastinum, and also in non-midline
structures including the lung, pancreas, kidney, bladder, endometrium,
and salivary gland. The WHO classification of tumors removed the
word “midline” from the name of this type of tumor and redefined it
as NC in 2015.4 Dutta et al. reported 10 cases of primary pulmonary
NC.5 NC of the lung was reported occurring near the hilum of the
lung; however, the majority of cases involving lung also demonstrate
mediastinum involvement at the time of diagnosis.5,6 Thus, these
cases were designated as thoracic NUT carcinoma as it is difficult to
decide the exact site of origin.
The treatment guidelines for pulmonary NC are similar to
the

guidelines

bromodomain

for
and

non-small

cell

extraterminal

lung

cancer.

inhibitors

and

Recently
histone

deacetylase inhibitors have emerged as two promising classes of
targeted therapy. 7,8
This is the first case regarding the study of cytological features
of NC of the lung with BRD3-NUTM1 fusion. The histocytomorphology of NCs ranges from monomorphic, primitive appearing
tumor cells that do not often stain for lineage-specific markers to
carcinoma with squamous differentiation and abrupt keratinization. National comprehensive cancer network (NCCN) guidelines
version 3.2020 for non-small cell lung cancer recommends testing
for NUT-expression in poorly differentiated carcinoma, and particularly in non-smokers or in patients presenting at a young age, for
consideration of pulmonary NC. Definite diagnosis of NC is made
by demonstration of NUT rearrangement by FISH or immunostaining by NUT-specific antibodies. We herein report cytological
findings of a primary NC of the lung with the BRD3-NUTM1
fusion gene.

F I G U R E 1 (A) PET-CT scan shows a right lung mass involving
pleura. (B) CT scan of the chest revealed a mass in right middle and
upper lung. (C) Chest X-ray with right sided pleural effusion
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C A S E P RE S E N T A T I O N

Endobronchial ultrasound-guided (EBUS) transbronchial fine-needle
aspiration (FNA) of the lung mass was done. Thoracocentesis was done,

A 36-year-old female presented with chest heaviness and short-

and pleural fluid was sent to the laboratory for cytological evaluation.

ness of breath. She was a non-smoker and had good health until

ThinPrep smears were air-dried and stained with Diff-Quick or wet fixed

her current illness. Chest X-ray (Figure 1C) showed massive right-

in 95% ethanol for Papanicolaou staining. Cell blocks were prepared, and

sided pleural effusion. CT-chest revealed an 8.5 x 6.8 cm hetero-

4um sections were stained with hematoxylin and eosin staining.

geneous mass in the right middle, and upper lung (Figure 1B).
PET-CT showed a hypermetabolic mass (7.9 x 6.7 cm) spanning
the right upper, middle and lower lung fields (Figure 1A). There
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Cytological findings

was also mediastinal and right hilar lymphadenopathy without
distant metastasis. The mass was clinically Stage IVA (cT4,

ThinPrep smear and cell block preparation of FNA material from right

cN2, pM1a).

lung mass showed cohesive groups of atypical squamoid cells with

F I G U R E 2 (A) Cohesive fragment of atypical squamous cells with keratinized squamous cells (ThinPrep smear of FNA, Papanicolaou, x200).
(B, C) Cohesive cluster of atypical cells with high n/c ratio and focus of squamous differentiation (ThinPrep smears of FNA, Papanicolaou, x200).
(D) Cohesive sheet of atypical cells with a subset having high n/c ratio, indistinct cell borders, and enlarged nuclei. Within this group, a second
population of tumor cells have smaller nuclei, distinct cell borders and abundant clear to eosinophilic cytoplasm (H & E, x200). (E and F)
Immunohistochemistry shows atypical cells positive for p40 and negative for TTF-1, respectively (IHC, x200)
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abundant dense cytoplasm and occasional orangeophilic keratinized
cells (Figure 2A). A focus of squamous differentiation was identified
within a cell group (Figure 2B). Cohesive fragments of atypical cells with
oval to spindle-shaped nuclei with hyperchromasia and high nuclear-tocytoplasmic (n/c) ratio were also seen (Figure 2C). Cell block preparation showed a cohesive sheet of atypical cells with a high n/c ratio,
indistinct cell borders, and enlarged nuclei. Within this group, there was
a second population of tumor cells that had smaller nuclei, distinct cell
borders, and abundant clear to eosinophilic cytoplasm (Figure 2D). The
tumor cells were diffusely positive for p40 (Figure 2E) and negative for
TTF-1 by immunohistochemistry (IHC; Figure 2F).
ThinPrep smears of the pleural fluid showed cohesive groups of cells
with enlarged, hyperchromatic nuclei and prominent nucleoli (Figure 3A).
Cell block preparation showed cohesive sheets of atypical squamoid cells
with distinct cell borders and abundant clear-to-eosinophilic cytoplasm
along with a monotonous population of tumor cells with a high n/c ratio
and indistinct cell borders (Figure 3B). Tumor cells with pavement-like
stratification were also appreciated (Figure 3C). Mitotic figures were identifiable; however, there was no nuclear molding, apoptosis, or necrosis.
IHC studies of the atypical cells in pleural fluid showed diffuse
positivity for p40, p63, CK7, and mCEA (Figure 4A–D), while negative
for TTF-1, Napsin A, D2-40, Calretinin, MOC31, BerEP4, and PDL-1.
The initial diagnosis of this case was squamous cell carcinoma of the
lung with pleural metastasis, although the clinical scenario was less
typical for it. The more primitive-looking groups of cells were thought
to represent the non-keratinized or less well-differentiated areas. Of
note, there was no history of HPV-related oropharyngeal lesion or
HPV-related cervical dysplasia. Molecular studies were negative for
coding variants or copy number alterations detected in the EGFR,
KRAS, NRAS, BRAF, MET, and ERBB2 targeted regions tested. Given
this uncharacteristic diagnosis in such a young and non-smoker
patient, we performed Fusion Panel-Solid Tumor (50 genes) study
searching for translocations and fusions with known and novel fusion
partners of 50 genes including NUT, considering the NCCN guidelines. The Fusion-panel was positive for BRD3-NUTM1 gene fusion
(Figure 4F). These findings confirmed the diagnosis of primary pulmonary NC with the BRD3-NUTM1 fusion gene with pleural metastasis.
Retrospectively, the IHC for NUT-specific antibody (C52B clone, rabbit monoclonal antibody, 1:200 dilution, cell signaling technology) was
performed, the results were equivocal as approximately 50% of the
tumor cells showed a weakly positive nuclear stain for it (Figure 4E).

2.2
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Treatment and follow up

F I G U R E 3 (A) ThinPrep smear shows a cohesive group with
enlarged, hyperchromatic cells with prominent nucleoli (ThinPrep
smear of pleural fluid, Papanicolaou, x200). (B, C) Fragments of
atypical tumor cells with focal squamous differentiation (H&E, x200)

The patient received chemotherapy consisting of carboplatin+Nab-Paclitaxel+Pembrolizumab. She received Denosumab for symptomatic hyper-

focal squamous differentiation in 33–40% of cases.9 Its true incidence

calcemia. She passed away eight months after the initial presentation.

remains unknown due to the low detection rate. NC is a diagnostic
challenge

for

pathologists

as

it

can

morphologically

mimic

undifferentiated carcinoma, squamous cell carcinoma, or neuroendo-
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DISCUSSION

crine carcinoma. The challenge is not how to diagnose NC but rather
determining when to include it in the differential diagnosis and per-

NC is a rare and aggressive type of carcinoma arising most often in a

form the diagnostic molecular tests (FISH or NGS) or IHC study for

midline structure. Although poorly differentiated, they display at least

NUT-specific antibody.
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F I G U R E 4 (A–D), Neoplastic cells positive for P40, P63, CK7 and mCEA (200). (E), nuclear protein in testis specific antibody showed weak
nuclear staining in up to 50% of the tumor cells (equivocal). (F), Fusion Panel- Solid Tumor (50 genes) revealed the presence of BRD3-NUTM1
fusion gene
Cytological findings of primary pulmonary NCs from previous

Similar to previously described cytological features of NC,10,11

studies show cohesive clusters and dispersed single monotonous,

this case also showed monomorphic, small to midsize, primitive appe-

small to medium-sized cells with primitive-appearing features and

aring tumor cells with scant cytoplasm. However, the majority of the

scant cytoplasm. Squamous differentiation in the form of abrupt

tumor cells appear to be atypical squamoid cells with oval to elon-

dyskeratotic cells or squamous cells with abundant dense cytoplasm is

gated nuclei, abundant clear to eosinophilic cytoplasm and rare indi-

noted in rare cases.10,11 A reported case of NC of the lung harboring

vidual cell keratinization or keratin pearl formation. Our initial

an NSD3-NUT fusion showed cellular smear with a non-cohesive pat-

cytological diagnosis was squamous cell carcinoma; further molecular

tern of monomorphic cells with a round-to-oval nucleus, slightly irreg-

study identified the BRD3-NUTM1 fusion gene. The diagnosis was

ular nuclear contours, variably prominent nucleoli, scant cytoplasm,

then amended to pulmonary NC with pleural metastasis. IHC for NUT

foci of stratification, and overt keratin pearl formation.12

specific antibody was performed retrospectively, which showed weak
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TABLE 1

Cytological and immunophenotypic features of primary pulmonary NC

References

Age/sex

Cytological diagnosis

P63

P40

Keratin

NEM

mCEA

58/M
35y/M

PDCA

ND

+

AE1/AE3+

+

MRCT

ND

+

AE1/AE3+

6

Dutta et al6

65y/F

PDCA

ND

+

ND

ND

ND

23y/F

PDCA

ND

+

CK 5/6+

ND

ND

6

Dutta et al6

32y/F

SQC

ND

+

CK 5/6+

ND

19/M

PDCA

ND

+

ND

ND

6

52/M

PDCA

+

ND

ND

ND

ND

Dutta et al6

37/M

PDCA

ND

+

ND

ND

ND

6

42/F

PDCA

ND

ND

ND

ND

ND

Dutta et al6

17/F

MC

ND

+

ND

ND

ND

34y/M

NET

+

ND

Dutta et al

6

Dutta et al6
Dutta et al

Dutta et al

Dutta et al

Dutta et al

Policarpio-Nicolas et al7

NUT

FISH

ND

+

ND

ND

+

ND

+

ND

+

ND

ND

+

ND

ND

+

ND

+

ND

+

ND

ND

TTF-1

ND

ND

ND

ND

+

ND

+

ND

+

ND

22y/M

NC

ND

ND

ND

ND

ND

ND

+

BRD4-NUT

Suzuki et al15

36y/F

UC

+

ND

AE1/AE3+

ND

ND

ND

+

NSD3-NUT

Lee at al16

45y/M

PDCA

ND

ND

AE1/AE3+

ND

+

ND

Lee at al16

32y/M

PDCA

+

ND

AE1/AE3+

ND

+

ND

Present study

36y/F

SQC

+

+

CK7+

+

ND

BRD3-NUT

Bishop et al

11

ND

Abbreviations: negative; + positive; MC, malignant cell present; MRCT, malignant round cell tumor; NC NUT, carcinoma; ND, not done; NEM,
neuroendocrine markers; NET, neuroendocrine tumor; NUT, nuclear protein in testis; PDCA, poorly differentiated carcinoma with abrupt squamous
differentiation; SCC, small cell carcinoma; SQC, squamous cell carcinoma; UC, undifferentiated carcinoma with cytoplasmic fine vacuoles.

nuclear staining in up to 50% of the tumor cells. The IHC result for

writing and editing. Yulei Shen contributed to data acquisition.

NUT-specific antibody was equivocal, and interpretation was made

Shereen Zia contributed to manuscript writing. Kyle Perry and Shan-

13

according to the previous guideline.

non Rodgers contributed to manuscript editing.

Sholl et al reviewed eight cases of pulmonary NCs with
BRD4-NUT rearrangement. All tumors expressed keratin, p63, and
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NUT protein.14 Suzuki et al. showed that the NSD3-NUT variant of NC
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vimentin, and NUT protein.15 A p63 negative primary pulmonary NUT
midline carcinoma with the BRD4-NUT fusion has been reported.9
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In conclusion, although the distinction of NC from other poorly
differentiated carcinomas based solely on morphology is difficult,
cytology can be helpful, especially for identifying abrupt keratinization. The cytological and IHC findings can be compatible with
keratinizing squamous cell carcinoma. However, when a specimen
demonstrates a dual cell population of squamoid cells and primitivelooking tumor cells in the wrong clinical context (i.e., young patient
with no smoking history), further molecular profiling is warranted to
include the differential of a primary NC of the lung.
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